Contracepção hormonal combinada interfere sobre a libido feminina?

Abstract

Contraceptive pills were introduced into the pharmacy market in the 1960s. Its creation brought a whole new perspective of liberty and sexuality into women’s life as never seen before. Since then, it has provided greater power of choice to women on when and whether pregnancy would occur in their lives, setting them free of the difficulties of an unexpected pregnancy. Studies have revealed that consumption of combined oral contraceptives (COC), also known as birth control pills, reduces levels of testosterone and other androgens causing sexual desire to decrease. This research aimed to identify a correlation between the intake of combined hormonal contraceptives versus sexual performance and female libido among nursing students in the campus of Sinop, Mato Grosso. For this, this analysis used an exploratory, descriptive and quantitative design. The site of study was the Federal University of Mato Grosso, Sinop campus. Data collection was performed between February and April of 2017 through two questionnaires. The first one obtained date regarding sociodemographic aspects and sexual anamnesis, and the second regarding a female version of Sexual Quotient (SQ-F). This investigation was registered and approved by the Research Ethics Committee under the registration number 375.106. Concerning libido, among those using of COC, 28.33% reported as having zero sexual desire while 57.14% of those who do not use it therapeutically informed as having. Orgasm was described by the majority of those who do not use hormonal contraceptives (NUHC) 42.86%, meaning that these women can reach climax; whereas 75% of those who use it (COC) cannot reach orgasm. With regards to the SQ-F, women who NUHC had their quotient classified as good to excellent, 33.33% of them. However, the intake of contraceptive showed a high correlation to SQ-F, negatively affecting it (classified as bad, 40%). Regarding sexual aspects, 78.33% of those who use COC reported some kind of dyspareunia, differently from 57.14% of the NUHC whom have not reported it. Analyzing the total set of participants, both those whose scores were or were not compatible with the diagnosis of sexual dysfunctions, the domain most affected was the (57.6%), orgasm (54.3%), excitation (50.6%) and satisfaction (31.7%), followed by dyspneumonia (58.8%), desire).This investigation concluded that between the surveyed populations, intake of combined hormonal contraceptive negatively influenced libido and, consequently, in one or more phases of the female sexual response.